Daxor Co. (NASDAQ:DXR) Sees Large Growth in Short Interest

Daxor Co. (NASDAQ:DXR) saw a large increase in short interest in June. As of June 30th, there was short interest totalling 8,700 shares, an increase of 14.5% from the June 15th total of 7,600 shares. Based on an average trading volume of 1,600 shares, the days-to-cover ratio is currently 5.4 days. Approximately 0.4% of the shares of the stock are short sold.

Daxor Price Performance

Shares of NASDAQ DXR remained flat at $9.20 during mid-day trading on Wednesday. The company had a trading volume of 50 shares, compared to its average volume of 976. Daxor has a 12 month low of $7.11 and a 12 month high of $10.15. The firm’s fifty day simple moving average is $9.13 and its 200 day simple moving average is $9.04.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.